NEW YORK (GenomeWeb News) – Opko Health has acquired Prost-Data, a Nashville, Tenn.-based CLIA laboratory doing business under the name OURLab.

Opko said that the acquisition would provide it with a commercial platform to support the US commercial launch of its 4Kscore protein biomarker prostate cancer test. The 4kscore test employs two protein biomarkers in the kallikrein family along with prostate-specific antigen for early detection of prostate cancer.

The lab has 18 phlebotomy sites throughout the US and a national sales force calling on urologists.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.